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Following the COVID-19 outbreak, significant changes have
been implemented on a national level in the organization of
neurology units and associated stroke units. Regionally-
designated COVID-19 hospitals have implemented an aggres-
sive policy to relocate as many beds as possible to COVID-19
patients. In order to do so, the preferred strategy has been to
reduce the number of beds in neurology units, and in some
cases several units have been consolidated into one. In other
cases, particularly in the northern regions, entire neurology
units have been closed and converted into COVID-19 depart-
ments entrusted to other medical specialties. Some stroke units
have followed the same path and become “hubs” and
“spokes” for acute neurological pathology. In other situations,
especially when it was necessary to meet the need for para-
medical staff, the number of beds in neurology/stroke wards
were significantly reduced and the nurses transferred to other
units as needed to manage the COVID-19 emergency.
During the COVID-19 emergency phase in March and
April 2020, only patients with acute neurological diseases,
including cerebrovascular disease, epilepsy, and other
acute pathologies, were admitted to neurology units of
COVID-19 hospitals. For all other patients with non-
acute central and peripheral nervous system diseases, hos-
pitalization was limited. Overall, the number of hospital-
ized neurological patients has undergone a drastic reduc-
tion. Some neurological patients have been hospitalized in
non-COVID-19 hospitals or in other non-neurological
wards, while a significant proportion of patients were
forced to postpone their request for hospitalization. In
addition to the reduced availability of beds, the COVID-
19 emergency has also resulted in the suspension of neu-
rological day hospitals, ambulatory care, complex outpa-
tient activity, and outpatient clinics, as well as clinics
dedicated to the diagnosis and treatment of specific cate-
gories of neurological patients (centers for epilepsy, neu-
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romuscular diseases, movement disorders, dementia,
headache, multiple sclerosis, amyotrophic lateral sclero-
sis, etc.).
In recent weeks, a slow but gradual reduction in the
COVID-19 emergency has been observed, and consequently
discussions are now taking place regarding the possible scal-
ing down of the government’s restrictive measures across the
country.
Considering the importance and impact of neurological
diseases on human health, it appears necessary to reopen,
albeit gradually, all neurological hospital admissions through-
out the country. Epidemiological data have overwhelmingly
demonstrated the impact of neurological diseases on human
health. Indeed, neurological diseases are among the leading
causes of mortality (i.e. cerebral stroke) and many determine
severe cognitive, mental, motor, and communication disabil-
ities that may seriously limit the social functions of patients
(neurodegenerative diseases) [1, 2]. A further aspect that
should not be underestimated involves possible post-
COVID-19 sequelae, which may require accurate follow-up
over time, as previously suggested by encephalitis lethargica
[3] and postpolio syndrome [4].
Neurology therefore has an urgent need to ensure an ade-
quate number of dedicated beds in university and non-
university hospitals in order to provide necessary care to a large
number of patients. Besides acute neurological pathologies,
neurological diseases include neurodegenerative conditions,
complex diseases from a diagnostic and therapeutic point of
view, and rare diseases that require specific experience and
skills. All these conditions have a significant impact on society
and families, who bear most of the burden in terms of care for
these patients. For patients suffering from chronic neurological
diseases, it is necessary to establish outpatient and dedicated
care pathways where patients can be followed up periodically
and where the effectiveness of therapeutic treatments in prog-
ress can be verified and monitored. The clinical course of these
patients must also be able to accommodate scheduled admis-
sions to neurology wards in the event of specific medical emer-
gencies. Home healthcare also requires careful planning.
The COVID-19 emergency has resulted in the total suspen-
sion of all healthcare assistance and therapeutic pathways,
which must be reopened and restored as soon as possible.
We need to prepare ourselves for the future and for other
emergencies by putting into practice the use of digital tech-
nologies that allow remote clinical evaluation and follow-up
of patients. The application of new technologies, particularly
those that permit the evaluation of patients at home, is already
urgently needed in order to reduce the influx of patients to
clinics and referral centers so as to comply with social distanc-
ing requirements.
COVID-19 reflects an unprecedented situation with a sig-
nificant impact on the traditional organization of neurology on
a national level. The awareness gained from this experience
must propel us to carefully and proactively plan for the future
so that the crucial role of neurology in managing emergencies
and chronic degenerative diseases is safeguarded and opti-
mized. The educational and proactive role of the academic
component of the neurology field must serve as a point of
reference, together with international and European regula-
tions, in order to develop an adequate strategy for the future
that takes into account the needs of the community, strategic
changes, the contribution of new technologies, and the ad-
vancement of science.
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